ALPHA TRIBE

Welcure Drugs & Pharmaceuticals LtdBoard Meeting, 02-09-2025: Board Meeting

02-09-2025 | 04:31 pm

Welcure Drugs' Board approved the FY25 Annual Report & MD&A. Key decisions included raising the FPI/FII/FDI/NRI investment limit to 49% of capital and expanding limits for loans/investments. A new Statutory Auditor was also appointed.

No comments yet. Be the first to comment!

All announcements from Welcure Drugs & Pharmaceuticals Ltd